While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo. These results come from the large, double-blind, randomized controlled trial conducted at 10 geographically diverse U.S. pediatric emergency departments. Findings were published in the New England Journal of Medicine.
"This study presents the most robust evidence to date that use of probiotics does not improve outcomes of acute gastroenteritis in children, which calls into question current recommendations," says the author. "Recommendations to use probiotics for these patients were based on previous meta-analyses that have suggested probiotics may be beneficial, but the trials that were included had significant limitations. The rigor of our research design and our results warrant reconsideration of common practice."
Acute gastroenteritis, which can present with diarrhea, vomiting and abdominal pain, accounts for approximately 1.7 million visits to the emergency department and more than 70,000 hospitalizations per year in the U.S. It is the second leading cause of death worldwide in children younger than 5 years.
The study included 943 children, aged 3 months to 4 years of age. Two weeks after an emergency department visit for acute gastroenteritis, children in the study who received a five-day course of probiotic (Lactobacillus rhamnosus) fared no better than the placebo group in terms of illness severity, duration and frequency of diarrhea or vomiting, day-care absenteeism and rate of household transmission of the infection.
https://www.luriechildrens.org/en/news-stories/probiotic-no-better-than-placebo-for-acute-gastroenteritis-in-children/
https://www.nejm.org/doi/full/10.1056/NEJMoa1802597?query=featured_home
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Genetic screen identifies genes that modulate Huntington disease's…
Read more
More than hundred autism genes mapped!
Read more
CRISPR 'minigene' approach stops genetic liver disease in mice
Read more
Reversing Huntington's disease-causing DNA repeat mutations in the lab
Read more
Linking genes with the ability to exercise
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar